首页>投融资
Mainstay
股权融资
Mainstay Medical是一家全球医疗器械公司,总部位于爱尔兰都柏林,业务遍及美国和澳大利亚。 他们与科学家和临床专家合作,为患有衰弱性慢性腰痛的大量服务不足的人群提供创新疗法。
基本信息
-
公司全称Mainstay Medical International PLC
-
类型医疗器械研发商
-
产业领域医疗器械、治疗设备
-
公司人数101~500人
-
地址77 Sir John Rogersons Quay Block C, Grand Canal Docklands Dublin, D02 VK60, Ireland
-
联系电话(877) 702-8488
-
邮箱info@mainstaymedical.com
-
成立时间2008-01-01
投融资
-
2024-02-26股权融资1.25亿美元Gilde HealthcareViking Global Investors汇桥资本Sofinnova PartnersFountain Healthcare PartnersPerceptive Advisors
-
2021-02-16股权融资1.08亿美元Sofinnova Partners汇桥资本Fountain Healthcare PartnersKCK Group
-
2020-04-07退市未透露未透露
-
2018-02-15上市后再融资3000万欧元KCK GroupFountain Healthcare PartnersSofinnova Partners
-
2016-06-17上市后再融资3000万欧元KCK Group
-
2015-08-24债权融资1500万美元IPF Partners
-
2014-04-29上市2500万美元未透露
-
2012-09-26B轮2000万美元Fountain Healthcare PartnersCapricorn Venture PartnersSeventure Partners
-
2010-07-01A轮610万美元Sofinnova Partners
- 加载更多
相关投融资企业
C轮
Francis Medical is a dynamic medical device company committed to developing urological cancer treatments that are tough on cancer yet gentle on patients.In September 2020, Coloplast announced that it has completed a USD 4m (DKK 25m) equity investment in Francis Medical
收并购
Gynesonics is a developer of transcervical, uterus-preserving, incision-free technologies for diagnostic and therapeutic applications (avoiding invasive surgical techniques of hysterectomy or myomectomy for symptomatic uterine fibroids). Products include the Sonata system which combines intrauterine ultrasound guidance with targeted radiofrequency ablation.In April 2023, the company closed a financing round of $25M
未公开
BetaGlue Therapeutics是一家临床分期肿瘤公司,该公司开发了一种先进的放疗平台,能够对不可切除的实体瘤和手术切缘进行局部靶向治疗,称为YntraDose。